Publications affiliated with IGNITE Network clinical studies are tagged accordingly. Other publications are relevant to human genetics and genomics and are either written by IGNITE Network investigators, affiliates, or other investigators.

Filter Categories
  • All ()
  • Archive ()
  • Clinical Implementation ()
  • Diagnosis ()
  • Education ()
  • EHRs ()
  • Gene-Disease ()
  • Genetic Testing ()
  • IGNITE Network ()
  • Meeting Summaries ()
  • Oncology ()
  • Other 'Omics ()
  • PGx ()
  • Policy ()
  • Rare/Undiagnosed Disease ()
  • Sequencing ()
  • Risk Assessment/FHH ()
July 19, 2023Publication, bias, genetic testing, health disparities, population databases, underrepresented minority

Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)

Dena R Matalon, Cinthya J Zepeda-Mendoza, Mahmoud Aarabi, Kaitlyn Brown, Stephanie M Fullerton, Shagun Kaur, Fabiola Quintero-Rivera, Matteo Vatta; ACMG Social, Ethical and Legal Issues Committee and the ACMG Diversity, Equity and...

Read More →
May 12, 2023Publication, antidepressents, genetic testing, genotypes, SNRIs, SSRIs

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Chad A Bousman, James M Stevenson, Laura B Ramsey, Katrin Sangkuhl, J Kevin Hicks, Jeffrey R Strawn, Ajeet B Singh, Gualberto Ruaño, Daniel J Mueller, Evangelia Eirini Tsermpini, Jacob T Brown, Gillian C Bell, J Steven Leeder, Andrea...

Read More →
February 3, 2023Publication, anticoagulation, atrial fibrillation, bleeding, DOAC, pharmacogenetics

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients

Alessandra M Campos-Staffico, Michael P Dorsch, Geoffrey D Barnes, Hao-Jie Zhu, Nita A Limdi, Jasmine A Luzum Abstract Background: Atrial fibrillation (AF) is the leading cause of ischemic stroke and treatment has focused on reducing...

Read More →
January 6, 2023Publication, medically underserved population, patient preferences, pharmacogenetic testing, qualitative research

Patients’ Perspectives of Factors That Influence Pharmacogenetic Testing Uptake: Enhancing Patient Counseling and Results Dissemination

Diliara Bagautdinova, Christelle Lteif, Elizabeth Eddy, Joshua Terrell, Carla L Fisher, Julio D Duarte Abstract Patient preferences for pharmacogenetic (PGx) counseling, testing and results dissemination are not well-established,...

Read More →
December 19, 2022Publication, clinical decision support, family history, precision medicine, risk assessment

Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities

R Ryanne Wu, Rachel A Myers, Joan Neuner, Catherine McCarty, Irina V Haller, Melissa Harry, Kimberly G Fulda, David Dimmock, Tejinder Rakhra-Burris, Adam Buchanan, Geoffrey S Ginsburg, Lori A Orlando Background: […]...

Read More →
June 16, 2021Publication

Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy

Pratt VM, Cavallari LH, Del Tredici AL, Gaedigk A, Hachad H, Ji Y, Kalman LV, Ly RC, Moyer AM, Scott SA, van Schaik RHN, Whirl-Carrillo M, Weck KE. J Mol […]...

Read More →
June 10, 2021Publication

PharmVar GeneFocus: CYP2C9

Sangkuhl K, Claudio-Campos K, Cavallari LH, Agundez J, Whirl-Carrillo M, Duconge J, Del Tredici AL, Wadelius M, Botton MR, Woodahl EL, Scott SA, Klein TE, Pratt VM, Daly AK, Gaedigk […]...

Read More →